CNSide Diagnostics logo
Order a Test

CNSide Expert Panel Recording: Advancing LM Diagnostics and Care

by | Sep 4, 2025 | News

Expert Insights on LM Care

CNSide Diagnostics is proud to share the recording of last month’s expert panel on leptomeningeal metastases (#LM) from the Society for Neuro-Oncology (SNO)/American Society of Clinical Oncology (ASCO) CNS Metastases Conference.

Leading neuro-oncology experts, including Dr. Priya Kumthekar, discussed the latest innovations in LM diagnostics and patient management, providing insights from both clinical practice and emerging research.

Watch the recording here: LM Expert Panel Recording

About CNSide Diagnostics

CNSide is advancing precision diagnostics for CNS cancers with its CSF assay platform, enabling:

  • Sensitive detection of CNS tumor cells
  • Longitudinal monitoring of leptomeningeal disease
  • Actionable insights to guide personalized treatment strategies

Learn more about our platform: CNSide Diagnostics

#CNSide #LeptomeningealMetastases #LM #CNSMetastases #NeuroOncology #BrainCancer #CancerDiagnostics #PrecisionMedicine #ClinicalResearch

Written By CNSide Diagnostics

undefined
More Posts by CNSide

Related Posts

Two New Strategic Executive Hires

Dec 9, 2025 |

Expanding operational and regulatory expertise to support commercialization and growth Plus Therapeutics (NASDAQ: PSTV) today announced two key leadership additions to CNSide Diagnostics, its wholly-owned subsidiary, further strengthening the company’s operational...

read more

Houston Business Journal

Dec 5, 2025 |

Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in...

read more

0 Comments